Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2697

Actual shortage: 241 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2447 (91%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

26 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR 300MG 200MG 600MG TABLET Resolved 2022-06-03 2023-02-11 161940
TEVA-EMTRICITABINE/TENOFOVIR 300MG 200MG TABLET Resolved 2022-04-21 2023-06-21 159201
TEVA-IRBESARTAN HCTZ 300MG 25MG TABLET Resolved 2021-06-10 2021-09-10 140681
TEVA-IRBESARTAN HCTZ 300MG 25MG TABLET Resolved 2023-11-03 2024-03-07 209122
TEVA-IRBESARTAN HCTZ 300MG 25MG TABLET Actual shortage 2024-04-11 2024-05-23 224898
TEVA-LENOLTEC NO. 3 300MG 30MG 15MG TABLET Resolved 2017-03-15 2017-12-15 2986
TEVA-LENOLTEC NO. 3 300MG 30MG 15MG TABLET Resolved 2019-12-19 2020-01-25 101707
TEVA-LENOLTEC NO. 3 300MG 30MG 15MG TABLET Resolved 2021-04-29 2021-05-06 138288
TEVA-LENOLTEC NO. 3 300MG 30MG 15MG TABLET Resolved 2024-04-18 2024-05-23 225477
TEVA-EMTEC-30 300MG 30MG TABLET Resolved 2021-02-18 2021-03-04 134346
TEVA-ABACAVIR/LAMIVUDINE 300MG 600MG TABLET Resolved 2021-10-21 2021-12-17 147699
TEVA-ABACAVIR/LAMIVUDINE 300MG 600MG TABLET Resolved 2022-08-18 2022-12-22 167237
TEVA-ABACAVIR/LAMIVUDINE 300MG 600MG TABLET Resolved 2023-06-08 2023-07-05 194180
TEVA-ABACAVIR/LAMIVUDINE 300MG 600MG TABLET Resolved 2023-06-16 2023-08-17 195072
TEVA-ABACAVIR/LAMIVUDINE 300MG 600MG TABLET Resolved 2023-06-20 2023-08-18 195900
TEVA-LENOLTEC NO. 4 300MG 60MG TABLET Resolved 2017-03-17 2017-09-05 3121
TEVA-LENOLTEC NO. 4 300MG 60MG TABLET Resolved 2019-12-12 2020-01-25 101145
TEVA-LENOLTEC NO. 4 300MG 60MG TABLET Resolved 2020-06-25 2020-07-23 118928
TEVA-LENOLTEC NO. 4 300MG 60MG TABLET Resolved 2020-10-01 2020-10-22 125458
TEVA-LENOLTEC NO. 1 300MG 8MG 15MG TABLET Resolved 2019-10-31 2020-07-23 97594

Showing 1701 to 1720 of 2697

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64626
RATIO-ATORVASTATIN Discontinued 2018-10-19 2018-10-19 64852
ACT CLOPIDOGREL Discontinued 2018-10-19 2018-10-19 65065
ACT TADALAFIL Discontinued 2018-10-22 2018-10-22 65284
ACT TADALAFIL Discontinued 2018-10-22 2018-10-22 65289
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81330
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81337
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81344
HYDROCORTISONE SODIUM SUCCINATE INJECTION Discontinued 2019-04-11 2019-04-11 81347
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106136
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106139
RATIO-SALBUTAMOL Discontinued 2020-02-13 2020-02-13 106151
GEMCITABINE FOR INJECTION Discontinued 2020-02-13 2020-02-13 106155
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106170
LINEZOLID INJECTION Discontinued 2020-02-13 2020-02-13 106173
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106176
TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION 0.004% SOLUTION Discontinued 2020-01-21 2020-01-21 103788
TEVA-ECTOSONE 0.1% LOTION Discontinued 2023-12-05 2023-12-05 212526
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION 0.375G 3G POWDER FOR SOLUTION Discontinued 2023-11-15 2023-11-15 210191
RATIO-TAMSULOSIN 0.4MG CAPSULE (SUSTAINED-RELEASE) Discontinued 2018-10-19 2018-10-19 64917

Showing 21 to 40 of 250